Insights on Site-of-Care Cancer Research: Both Quality and Cost Information Are Necessary to Guide Policy
The implementation of alternative payment models that successfully capture clinical heterogeneity—without adding unacceptable levels of administrative complexity—may be equally (if not more) important than site-neutral payment policies.
